Sorry, but you do not have permission to view this content.
Category Archives: Prescription Drugs
ERIC Submits Comments on Maine Biosimilar Bill
Today, ERIC submitted comments to the Maine House Committee on Health Coverage, Insurance and Financial Services regarding Legislative Document 659, which would allow pharmacists to make biosimilar substitutions
ERIC Submits Comments on Arkansas Biosimilar Bill
Today, ERIC submitted comments to the Arkansas House Public Health, Welfare and Labor Committee on House Bill 1269, which would allow pharmacists to make biosimilar substitutions
Rx CEOs Grilled on the Hill – Rx Feedback Needed; Last Call on Caddy Tax Letter
Sorry, but you do not have permission to view this content.
Surprise Billing, Rx Update, Wilderness Therapy, Retiree Health and CBAs
Sorry, but you do not have permission to view this content.
Surprise billing, Commonwealth Fund on underinsurance, Rx cost latest, and more!
Sorry, but you do not have permission to view this content.
Rx Rebate Mayhem, Amicus Filed in 5th Circuit, New Caddy Data, More!
Sorry, but you do not have permission to view this content.
Event invite, PCORI – Member feedback needed, Rx hearings, and More!
Sorry, but you do not have permission to view this content.
ERIC Comments on Modernizing Part D & Medicare Advantage to Lower Drug Prices & Reduce Costs
Today, ERIC submitted comments to the Center for Medicare and Medicaid Services in response to the Proposed Rule on “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses’
DOL on MHP, State health initiatives, Rx cost update
Sorry, but you do not have permission to view this content.